Immunicum is listed on NASDAQ Stockholm under the ticker IMMU
Tweets by @Immunicum
Tweets by ImmunicumPress Releases
Immunicum AB (publ) Interim Report January – June 2019
20 Aug 2019Immunicum AB (publ) Announces New Issuance Date for Interim Report April – June 2019 and Corporate Update Event
28 Jun 2019Immunicum AB (publ) Announces Positive Topline Results from the Phase I/II Clinical Trial in GIST
12 Jun 2019
Latest Corporate presentation
Quarterly Report Presentation & Business Strategy video - 20 Aug 2019 Corporate presentation August 2019News
-
Quarterly Report Presentation & Business Strategy video & slides
21 Aug 2019 -
Corporate Update Event video
20 Aug 2019 -
Cell & Gene Therapy Insights 2019 – Abstract
9 Jul 2019 -
Edison Report from 27 June 2019
1 Jul 2019 -
Immunicum utvecklar banbrytande cancerstrategi – Radiumhemmets Forskningsfonder Article
29 May 2019
About us
Developing innovative cancer immunotherapies
Immunicum is advancing a novel cell-based approach to target solid tumors.
Learn more
